Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ariad Pharmaceuticals history
Ariad Pharmaceuticals company history timeline
ARIAD filed for an initial public offering through NASDAQ in 1994.
On February 21, 2014 ARIAD Pharmaceuticals announced the appointment of Sarissa Capital's Alexander J. Denner, Ph.D. to a two-year term on the company's Board of Directors and became ARIAD's second-largest shareholder.
In July 2015, the company announced it was due to receive up to $200 million through a royalty financing deal with PDL BioPharma.
In 2016, ARIAD announced that Denner had become the chairman of the board and the company announced the termination of its shareholder's rights plan.
In 2016, the company was ranked #3 on the Deloitte Fast 500 North America list.
Rate how well Ariad Pharmaceuticals lives up to its initial vision.
Ariad Pharmaceuticals jobs
Do you work at Ariad Pharmaceuticals?
Does Ariad Pharmaceuticals communicate its history to new hires?
Ariad Pharmaceuticals competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Amylin Pharmaceuticals | 1987 | $650.7M | 1,300 | - |
| Merck | 1891 | $64.2B | 74,000 | 1,402 |
| ImmunoGen | 1981 | $108.8M | 75 | - |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 892 |
| Zoetis | 1952 | $9.3B | 11,300 | 231 |
| Cubist Pharmaceuticals | 1992 | $926.4M | 873 | - |
| Hoffmann-LA Roche Inc | 1896 | $60.9B | 101,200 | 127 |
| Nanotherapeutics, Inc. | - | - | - | - |
| PTC Therapeutics | 1998 | $806.8M | 517 | 8 |
| Astex Pharmaceuticals | 1999 | $83.2M | 142 | - |
Ariad Pharmaceuticals history FAQs
Zippia gives an in-depth look into the details of Ariad Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ariad Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Ariad Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ariad Pharmaceuticals. The data presented on this page does not represent the view of Ariad Pharmaceuticals and its employees or that of Zippia.
Ariad Pharmaceuticals may also be known as or be related to ARIAD PHARMACEUTICALS INC, ARIAD Pharmaceuticals, ARIAD Pharmaceuticals, Inc., Ariad Pharmaceuticals, Ariad Pharmaceuticals Inc and Ariad Pharmaceuticals, Inc.